358 related articles for article (PubMed ID: 18445740)
1. Imaging of mild cognitive impairment and early dementia.
Schuff N; Zhu XP
Br J Radiol; 2007 Dec; 80 Spec No 2():S109-14. PubMed ID: 18445740
[TBL] [Abstract][Full Text] [Related]
2. The role of neuroimaging in mild cognitive impairment.
Matsuda H
Neuropathology; 2007 Dec; 27(6):570-7. PubMed ID: 18021379
[TBL] [Abstract][Full Text] [Related]
3. Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia.
Fayed N; Dávila J; Oliveros A; Castillo J; Medrano JJ
Acad Radiol; 2008 Sep; 15(9):1089-98. PubMed ID: 18692749
[TBL] [Abstract][Full Text] [Related]
4. A critical discussion of the role of neuroimaging in mild cognitive impairment.
Wolf H; Jelic V; Gertz HJ; Nordberg A; Julin P; Wahlund LO
Acta Neurol Scand Suppl; 2003; 179():52-76. PubMed ID: 12603252
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of FDG-PET and HMPAO-SPET in patients with mild dementia and mild cognitive impairment: metabolic index and perfusion index.
Döbert N; Pantel J; Frölich L; Hamscho N; Menzel C; Grünwald F
Dement Geriatr Cogn Disord; 2005; 20(2-3):63-70. PubMed ID: 15908747
[TBL] [Abstract][Full Text] [Related]
6. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
[TBL] [Abstract][Full Text] [Related]
7. FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment.
Chételat G; Eustache F; Viader F; De La Sayette V; Pélerin A; Mézenge F; Hannequin D; Dupuy B; Baron JC; Desgranges B
Neurocase; 2005 Feb; 11(1):14-25. PubMed ID: 15804920
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study.
Fellgiebel A; Wille P; Müller MJ; Winterer G; Scheurich A; Vucurevic G; Schmidt LG; Stoeter P
Dement Geriatr Cogn Disord; 2004; 18(1):101-8. PubMed ID: 15087585
[TBL] [Abstract][Full Text] [Related]
9. MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias.
Meyer JS; Huang J; Chowdhury MH
J Neurol Sci; 2007 Jun; 257(1-2):97-104. PubMed ID: 17316690
[TBL] [Abstract][Full Text] [Related]
10. Neuroimaging in human immunodeficiency virus infection.
Tucker KA; Robertson KR; Lin W; Smith JK; An H; Chen Y; Aylward SR; Hall CD
J Neuroimmunol; 2004 Dec; 157(1-2):153-62. PubMed ID: 15579293
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.
Smith EE; Egorova S; Blacker D; Killiany RJ; Muzikansky A; Dickerson BC; Tanzi RE; Albert MS; Greenberg SM; Guttmann CR
Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography imaging in dementia.
Herholz K; Carter SF; Jones M
Br J Radiol; 2007 Dec; 80 Spec No 2():S160-7. PubMed ID: 18445746
[TBL] [Abstract][Full Text] [Related]
13. Magnetization transfer ratio in mild cognitive impairment and dementia of Alzheimer's type.
Kabani NJ; Sled JG; Chertkow H
Neuroimage; 2002 Mar; 15(3):604-10. PubMed ID: 11848703
[TBL] [Abstract][Full Text] [Related]
14. Diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease: a review.
Chua TC; Wen W; Slavin MJ; Sachdev PS
Curr Opin Neurol; 2008 Feb; 21(1):83-92. PubMed ID: 18180656
[TBL] [Abstract][Full Text] [Related]
15. [Current topics about mild cognitive impairment (MCI)].
Yamamoto Y
Seishin Shinkeigaku Zasshi; 2011; 113(6):584-92. PubMed ID: 21815470
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography in at risk patients and in the progression of mild cognitive impairment to Alzheimer's disease.
Rinne JO; Någren K
J Alzheimers Dis; 2010; 19(1):291-300. PubMed ID: 20061645
[TBL] [Abstract][Full Text] [Related]
17. Mild cognitive impairment: an overview.
Petersen RC; Negash S
CNS Spectr; 2008 Jan; 13(1):45-53. PubMed ID: 18204414
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosing the mild cognitive impairment stage of Alzheimer's disease].
Maruyama M; Matsui T; Tanji H; Ootsuki M; Nemoto M; Tomita N; Okamura N; Matsushita S; Higuchi S; Kodama M; Arai H; Sasaki H
Seishin Shinkeigaku Zasshi; 2004; 106(3):269-80. PubMed ID: 15164576
[TBL] [Abstract][Full Text] [Related]
19. The value of diffusion tensor imaging in the differential diagnosis of subcortical ischemic vascular dementia and Alzheimer's disease in patients with only mild white matter alterations on T2-weighted images.
Fu JL; Zhang T; Chang C; Zhang YZ; Li WB
Acta Radiol; 2012 Apr; 53(3):312-7. PubMed ID: 22416261
[TBL] [Abstract][Full Text] [Related]
20. White matter damage in Alzheimer disease and mild cognitive impairment: assessment with diffusion-tensor MR imaging and parallel imaging techniques.
Stahl R; Dietrich O; Teipel SJ; Hampel H; Reiser MF; Schoenberg SO
Radiology; 2007 May; 243(2):483-92. PubMed ID: 17456872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
